Malaria is an infectious disease characterized by cycles of chills, fever, and sweating, caused by a protozoan of the genus Plasmodium in red blood cells, which is transmitted to humans by the bite of an infected female anopheles mosquito.
Scientists release data on potential new treatment targets for malaria – International collaboration led by St. Jude Children’s Research Hospital scientists identifies promising compounds for anti-malarial drug development and launches a database to share findings, advance fight against a leading killer of the world’s children
Success against malaria bolsters case for further investment, new report shows — World Vision cites analysis released today by Roll Back Malaria Partnership. – A new study linking funding increases in the global fight against malaria to a drop in deaths from the disease also shows that resources from donor governments still fall short of those needed for maximum impact against the world’s fourth-biggest killer of children, according to a global health policy analyst at international aid agency World Vision.
Study examines family lineage of King Tut, his possible cause of death – Malaria and bone abnormalities appear to have contributed to the death of Egyptian pharaoh King Tutankhamun, revealed by researchers.
Quantifying the number of pregnancies at risk of malaria in 2007: A demographic study – Research published this week in PLoS Medicine concludes that at least 125.2 million women at risk of malaria become pregnant each year.
Promising candidates for malaria vaccine revealed – Walter and Eliza Hall Institute researchers have uncovered a group of proteins that could form the basis of an effective vaccine against malaria.
Measuring and modeling blood flow in malaria — Fluid Dynamics Conference in Minneapolis highlights – When people have malaria, they are infected with Plasmodium parasites, which enter the body from the saliva of a mosquito, infect cells in the liver, and then spread to red blood cells.
Gates Foundation funds development of coffee ring stain diagnostic test for malaria – The US’ Gates Foundation funds development of coffee ring stain diagnostic test for malaria. Vanderbilt University received a $100,000 Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation.
Threat of resistance to artemisinin-based anti-malarial drugs highlighted by new study – Malaria parasites in western Cambodia have become resistant to artemisinin based therapies, the first-line treatment for malaria, revealed by researchers.
New lead on malaria treatment – Variation of natural compound cures malaria in mice. – Approximately 350 million to 500 million cases of malaria are diagnosed each year mostly in sub-Saharan Africa. While medications to prevent and treat malaria do exist, the demand for new treatments is on the rise, in part, because malaria parasites have developed a resistance to existing medications.
Ranbaxy commences phase-iii clinical trials for its new anti-malarial molecule. The drug aims to transform the treatment of malaria in developing countries. – Ranbaxy Laboratories Limited (Ranbaxy) announced the commencement of Phase-III clinical trials for its new Anti-malaria combination drug, Arterolane maleate + Piperaquine phosphate in India, Bangladesh and Thailand.
